AEON Biopharma Statistics

Total Valuation

AEON Biopharma has a market cap or net worth of $22.27 million. The enterprise value is $33.52 million.

Market Cap	22.27M
Enterprise Value	33.52M

Important Dates

The last earnings date was Wednesday, November 13, 2024, after market close.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

AEON Biopharma has 39.52 million shares outstanding. The number of shares has decreased by -68.99% in one year.

Current Share Class	39.52M
Shares Outstanding	39.52M
Shares Change (YoY)	-68.99%
Shares Change (QoQ)	+4.23%
Owned by Insiders (%)	6.13%
Owned by Institutions (%)	6.68%
Float	14.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.39

Current Ratio	0.39
Quick Ratio	0.33
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-597.69%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$30.55M
Employee Count	10
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -87.28% in the last 52 weeks. The beta is 0.40, so AEON Biopharma's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	-87.28%
50-Day Moving Average	0.90
200-Day Moving Average	3.71
Relative Strength Index (RSI)	26.24
Average Volume (20 Days)	115,776

Short Selling Information

The latest short interest is 137,444, so 0.35% of the outstanding shares have been sold short.

Short Interest	137,444
Short Previous Month	133,685
Short % of Shares Out	0.35%
Short % of Float	0.96%
Short Ratio (days to cover)	0.78

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-43.96M
Pretax Income	-323.95M
Net Income	-305.52M
EBITDA	-43.86M
EBIT	-43.96M
Earnings Per Share (EPS)	-$7.10

Full Income Statement

Balance Sheet

The company has $3.44 million in cash and $14.69 million in debt, giving a net cash position of -$11.25 million or -$0.28 per share.

Cash & Cash Equivalents	3.44M
Total Debt	14.69M
Net Cash	-11.25M
Net Cash Per Share	-$0.28
Equity (Book Value)	-27.95M
Book Value Per Share	-0.71
Working Capital	-6.41M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-43.40M
Capital Expenditures	n/a
Free Cash Flow	-43.40M
FCF Per Share	-$1.10

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AEON Biopharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	68.99%
Shareholder Yield	68.99%
Earnings Yield	-1,371.60%
FCF Yield	-194.83%

Analyst Forecast

The average price target for AEON Biopharma is $5.00, which is 787.15% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.00
Price Target Difference	787.15%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3